Thermo Fisher – 2023 new APS classification criteria
Thermo Fisher EliA testing for antiphospholipid syndrome (APS) in relation to the new 2023 APS classification criteria.
Thermo Fisher EliA testing for antiphospholipid syndrome (APS) in relation to the new 2023 APS classification criteria.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
We are pleased to launch the 2024 edition of the Thermo Fisher Phadia product catalogue for ImmunoCAP and EliA.
Products are for professional/laboratory use only.
An allergy diagnosis is based on the history, clinical symptoms and physical examination of the patient in combination with results of sIgE tests.
Products are for professional/laboratory use only.
An allergy diagnosis is based on the history, clinical symptoms and physical examination of the patient in combination with results of sIgE tests.
Products are for professional/laboratory use only.
An allergy diagnosis is based on the history, clinical symptoms and physical examination of the patient in combination with results of sIgE tests.
Products are for professional/laboratory use only.
An allergy diagnosis is based on the history, clinical symptoms and physical examination of the patient in combination with results of sIgE tests.
Products are for professional/laboratory use only.
An allergy diagnosis is based on the history, clinical symptoms and physical examination of the patient in combination with results of sIgE tests.
Products are for professional/laboratory use only.
An allergy diagnosis is based on the history, clinical symptoms and physical examination of the patient in combination with results of sIgE tests.